Assessment of Therapeutic Effect of Rectal Vs. Intravenous Paracetamol in The Treatment of Patent Ductus Arteriosus (PDA) in Neonates
A phase 1/2 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 100 participants.
Also called NCT06256211
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose treatment
- Phase
- Phase 1/2
- Enrolled
- 100 participants
- Sponsor
- Registry
-
NCT06256211
-
- Planned start
- (anticipated)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Not reported
- Registry status
- Unknown status
Technical summary
Registry record NCT06256211. Randomized; single masking; primary purpose treatment. Start 2024-03-01 (anticipated); primary completion 2024-11-01 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Assessment of Therapeutic Effect of Rectal Vs. Intravenous Paracetamol in The Treatment of Patent Ductus Arteriosus (PDA) in Neonates
- Condition
- Patent Ductus Arteriosus
- Intervention (Drug)
- Paracetamol
- Lead sponsor
- Soha mahmoud Hussien mahdy
- Collaborator
- Assiut University
Record details
- Record id
cardio:ct-nct06256211- Content hash
69f83d724859d567c1ef343864617d638d6000d045988b2f927ec7276cf85fad